Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study
Asian Journal of Transfusion Science · 2023-07 · 17 (2) · 239-245
DOI: 10.4103/ajts.ajts_73_22 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Asian Journal of Transfusion Science, online erschienen am 12.12.2022. Verfasst von Esha Toora und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
INTRODUCTION: In blood banking and transfusion medicine, it is of paramount importance to improve transfusion safety and provide a higher quality of product to maximize the therapeutic outcomes and minimize the risk of developing transfusion-associated complications for patients receiving a blood transfusion. MATERIALS AND METHODS: This was a cross-sectional study conducted at the department of transfusion medicine in a tertiary care hospital of South India from February 2019 to December 2020. The primary objective of the study was to assess the quality of platelet concentrates (PC) prepared by platelet-rich plasma (PRP), buffy-coat (BC), and apheresis method. A total of 760 PCs were subjected to quality assessment, among which 124 were PRP-PC, 176 were BC-PC, and 460 were single donor platelet (SDP). RESULTS: The total percentage of platelets meeting all the six quality control parameters in PRP, BC and SDP was 78.23%, 81.81%, and 89.96%, respectively. Apheresis PCs showed a significantly higher platelet concentration per µL on comparison with whole-blood-derived platelets. BC-PCs were found to be better than PRP-PC with regard to lower white blood cell (WBC) contamination ( P < 0.05) and red blood cell (RBC) contamination ( P < 0.01). No statistically significant difference was found with regard to platelet yield, volume, swirling, and pH. CONCLUSION: Ex vivo quality of PCs prepared by BC-PC, PRP-PC, and apheresis-PC fulfilled the desired quality control parameters. BC-PC was better than PRP-PC in terms of lesser WBC and RBC contamination and comparable in terms of volume, platelet yield, swirling, and pH. Apheresis PCs showed a higher platelet concentration per microliter on comparison with whole-blood-derived platelets; hence in a blood center where facilities for collection of apheresis product are available, SDPs should be the choice of platelet transfusion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Transfusion Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Zitieren
APA
Toora, E., Kulkarni, R. G., Manivannan, P., Sastry, A. S., Basavarajegowda, A., & Sahoo, D. (2023). Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study. Asian Journal of Transfusion Science, 17(2), 239-245. https://doi.org/10.4103/ajts.ajts_73_22
Vancouver
Toora E, Kulkarni RG, Manivannan P, Sastry AS, Basavarajegowda A, Sahoo D. Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study. Asian Journal of Transfusion Science. 2023;17(2):239-245. doi:10.4103/ajts.ajts_73_22
BibTeX
@article{Toora2023,
author = {Toora, Esha and Kulkarni, Rajendra G and Manivannan, Prabhu and Sastry, Apurba Sankar and Basavarajegowda, Abhishekh and Sahoo, Dibyajyoti},
title = {Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study},
journal = {Asian Journal of Transfusion Science},
year = {2023},
volume = {17},
number = {2},
pages = {239--245},
doi = {10.4103/ajts.ajts_73_22}
}
EUVIMED